Becton Dickinson & Co (BDX)
224.00
-1.45
(-0.64%)
USD |
NYSE |
Nov 22, 16:00
224.04
+0.04
(+0.02%)
Pre-Market: 20:00
Becton Dickinson Cash from Investing (Quarterly): -3.937B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.937B |
| June 30, 2024 | -288.00M |
| March 31, 2024 | -1.056B |
| December 31, 2023 | -233.00M |
| September 30, 2023 | 137.00M |
| June 30, 2023 | -329.00M |
| March 31, 2023 | -233.00M |
| December 31, 2022 | -291.00M |
| September 30, 2022 | -2.005B |
| June 30, 2022 | -236.00M |
| March 31, 2022 | -304.00M |
| December 31, 2021 | -686.00M |
| September 30, 2021 | -694.00M |
| June 30, 2021 | -323.00M |
| March 31, 2021 | -433.00M |
| December 31, 2020 | -430.00M |
| September 30, 2020 | -327.00M |
| June 30, 2020 | -363.00M |
| March 31, 2020 | -255.00M |
| December 31, 2019 | -287.00M |
| September 30, 2019 | -441.00M |
| June 30, 2019 | -330.00M |
| March 31, 2019 | -269.00M |
| December 31, 2018 | 299.00M |
| September 30, 2018 | -560.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 200.00M |
| March 31, 2018 | -170.00M |
| December 31, 2017 | -15.20B |
| September 30, 2017 | -347.00M |
| June 30, 2017 | -381.00M |
| March 31, 2017 | -203.00M |
| December 31, 2016 | 48.00M |
| September 30, 2016 | -351.00M |
| June 30, 2016 | -148.00M |
| March 31, 2016 | -25.00M |
| December 31, 2015 | -145.00M |
| September 30, 2015 | -315.00M |
| June 30, 2015 | -174.00M |
| March 31, 2015 | -8.197B |
| December 31, 2014 | 368.00M |
| September 30, 2014 | -218.00M |
| June 30, 2014 | -232.00M |
| March 31, 2014 | -231.00M |
| December 31, 2013 | -267.00M |
| September 30, 2013 | -607.00M |
| June 30, 2013 | -119.00M |
| March 31, 2013 | 25.00M |
| December 31, 2012 | 390.00M |
| September 30, 2012 | -251.83M |
| June 30, 2012 | -422.16M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.937B
Minimum
Sep 2024
137.00M
Maximum
Sep 2023
-628.65M
Average
-325.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Abbott Laboratories | -594.00M |
| Baxter International Inc | -164.00M |
| Merit Medical Systems Inc | -115.67M |
| ResMed Inc | 2.146M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.179B |
| Cash from Financing (Quarterly) | 124.00M |
| Free Cash Flow | 3.073B |
| Free Cash Flow Per Share (Quarterly) | 3.038 |
| Free Cash Flow to Equity (Quarterly) | 96.00M |
| Free Cash Flow to Firm (Quarterly) | 959.90M |
| Free Cash Flow Yield | 4.72% |